Ingrid Bassett, MD, MPH
Massachusetts General Hospital
Dr. Ingrid Bassett is an Associate Professor of Medicine at Harvard Medical School and physician at the Massachusetts General Hospital Division of Infectious Disease. She also serves as the Co-Director of the Harvard Center for AIDS Research. Dr. Bassett investigates innovative solutions in expanding access to HIV testing, treatment and prevention outside of the “brick and mortar” healthcare setting and in community venues in South Africa, the epicenter of the HIV epidemic. Please see Dr. Basset’s Harvard Catalyst Profile for selected publications.
Michael R. Jordan, MD, MPH
Tufts Medicine
Dr. Michael R. Jordan is an attending physician in the Division of Infectious Diseases and Geographic Medicine at Tufts Medicine and is an Associate Professor of Medicine and Public Health and Community Medicine at Tufts University School of Medicine. Dr. Jordan is board certified in Infectious Diseases and is Tufts University’s Infection Control Health Director.
Dr. Jordan is an internationally recognized expert in HIV drug resistance (HIVDR), public health surveillance epidemiology, and antiretroviral therapy (ART) program evaluation and monitoring. Dr. Jordan is the Director of Tufts Medicine/Tufts University COVID-19 Biorepository and Comprehensive COVID-19 Database, which is designed to accelerate research efforts in basic pathophysiology, diagnostics, vaccines, treatments, and clinical determinants and outcomes. Please see Dr. Jordan’s Tuft’s Medicine Profile for selected publications.
Jai Marathe, MBBS
Boston Medical Center
Dr. Jai Marathe is an Assistant Professor of Medicine in the Section of Infectious Diseases, Boston University School of Medicine and is a graduate from the Infectious Diseases fellowship program at Boston Medical Center. She is the Associate Director of Boston Medical Center’s Special Pathogens Unit. Dr. Marathe’s research spans HIV transmission across reproductive mucosa and the potential for topical use of various plant-derived antibodies (plantibodies) in prevention of HIV infection. During the Covid-19 pandemic, she has worked to provide outpatient support, telemedicine follow-up and infusion of anti Covid-19 monoclonal antibodies to patients diagnosed with Covid-19 disease. As the Medical Director for Boston Medical Center’s Center for Infectious Disease, Dr. Marathe’s current research and clinical interest lies at the intersection of clinical care for long COVID patients, clinical outcomes and the pathophysiology of PASC/Long COVID. She currently serves as the Director of Boston Medical Center’s Long COVID clinic and a site PI for NIH RECOVER study. Please see Dr. Marathe’s Boston University profile for selected publications.
Janet Mullington, PhD
Beth Israel Deaconess Medical Center
Dr. Janet Mullington is Professor of Neurology at the Beth Israel Deaconess Medical Center and Harvard Medical School. Her area of expertise and research is in sleep deficiency and its associated pathobiological consequences for systems including inflammatory, autonomic, state-related neurosphysiology, cognitive and subjective fatigue and mood. Her research team uses highly controlled approaches to induce experimental sleep deficiency of different durations (doses) to study effects of the build-up of deficiency in healthy sleepers, as well as the recovery process when sleep resumes. In addition, translational work of her group tests the efficacy of manipulating the timing and duration of sleep in order to lower blood pressure in individuals with hypertension, with particular interest in sex differences.
Dr. Mullington is a Past President of the SRS and is currently co-chair of the SRS Advocacy Taskforce and a member of the SRS Sleep Research Network Taskforce. She serves as the Program Director for the Beth Israel Deaconess Medical Center’s Clinical Research Center, one of the Harvard Clinical and Translational Science Award funded research units, which supports early career stage researchers and clinical investigation across the departments and divisions of the medical center. She is also Vice Chair for Research in the Department of Neurology at the BIDMC. Please see Dr. Mullington’s Harvard Catalyst Profile for a list of publications.
Howard D. Sesso, ScD, MPH, FAHA
Brigham & Women’s Hospital
Dr. Howard D. Sesso is an Associate Epidemiologist at the Division of Preventive Medicine at Brigham and Women’s Hospital, Associate Professor of Medicine at Harvard Medical School, and Associate Professor of Epidemiology at the Harvard T.H. Chan School of Public Health. He designs and conducts randomized clinical trials and epidemiologic studies, focusing on dietary supplements, nutrition, and lifestyle factors to prevent cardiovascular disease (CVD), hypertension, cancer, and other aging-related outcomes. Dr. Sesso is Associate Director of the Division of Preventive Medicine and Director of Nutrition and Supplement Research at the Osher Center for Integrative Health. Dr. Sesso has been involved in several major trials at the Division of Preventive Medicine, helping lead the Physicians’ Health Study (PHS), conducting several ancillary studies in the VITamin D and OmegA-3 TriaL, and co-leading the COcoa Supplement and Multivitamin Outcomes Study (COSMOS). He has also conducted several small-scale clinical trials testing dietary supplements, including the VItamin D for COVID (VIVID) trial. Dr. Sesso is the Hub PI for the Boston COVID Recovery Cohort as part of the RECOVER study, for which he was involved in the RECOVER Study Design Committee to shape the surveys and assessments for the cohort. A list of Dr. Sesso’s publications can be found on Pubmed.
Jeffrey A. Sparks, MD, MSSc
Brigham & Women’s Hospital
Dr. Jeffrey A. Sparks is a rheumatologist and Associate Professor of Medicine at Mass General Brigham / Brigham and Women’s Hospital and Harvard Medical School in Boston, Massachusetts. Dr. Sparks serves as the Director of Immuno-Oncology and Director of the Rheumatoid Arthritis Program for the Division of Rheumatology, Inflammation, and Immunity. His research focuses on using patient-oriented and epidemiologic methods to evaluate the etiology, outcomes, and public health burden of rheumatic diseases. His research themes are rheumatoid arthritis risk and outcomes related to pulmonary disease, infections and rheumatic disease risk and outcomes, and rheumatic immune-related adverse events from immunotherapy for cancer treatment. He has received research awards from the National Institutes of Health, American College of Rheumatology, European Alliance of Rheumatology Associations, Rheumatology Research Foundation, Arthritis Foundation, Brigham and Women’s Hospital, Brigham Research Institute, and Harvard Medical School.
Honorine Ward, MD
Tufts Medical Center
Dr. Honorine Ward is Professor of Medicine at Tufts University School of Medicine. She is on the faculty of the Immunology and Molecular Microbiology Graduate Programs at Tufts Graduate School of Biomedical Sciences and the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center. She obtained her medical training at the Christian Medical College in Vellore, India and post-doctoral training at Tufts. Dr. Ward’s research focuses on the molecular basis of Cryptosporidium-host cell interactions and her global health work in India is directed at immune responses to Cryptosporidium and the gut microbiome in childhood malnutrition and diarrheal diseases. Since the onset pandemic of the pandemic she has coordinated the Tufts COVID-19 Biorepository and Comprehensive Database. She is interested in the role of the gut microbiome in Post Acute SARS-CoV2 infection. A list of Dr. Ward’s publications can be found on Pubmed.